Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancerRECK, Martin; CRINO, Lucio.Lung cancer. 2009, Vol 63, Num 1, pp 1-9, issn 0169-5002, 9 p.Article

Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settingsCRINO, Lucio; CAPPUZZO, Federico.Lung cancer. 2001, Vol 34, pp S45-S47, issn 0169-5002, SUP3Conference Paper

Present and future treatment of advanced non-small cell lung cancerCRINO, Lucio; CAPPUZZO, Federico.Seminars in oncology. 2002, Vol 29, Num 3, pp 9-16, issn 0093-7754, SUP9Article

Development of new first-line therapeutic options for non-small-cell lung cancerCRINO, Lucio; FOGLIETTA, Jennifer; HAMZAJ, Alketa et al.Lung cancer. 2006, Vol 54, issn 0169-5002, S19-S24, SUP2Article

Pemetrexed combination therapy in the treatment of non-small cell lung cancerROSELL, Rafael; CRINO, Lucio.Seminars in oncology. 2002, Vol 29, Num 2, pp 23-29, issn 0093-7754, SUP5Conference Paper

Combined platinum containing treatment in NSCLCCRINO, Lucio.Lung cancer. 2002, Vol 38, pp S51-S52, issn 0169-5002, SUP3Article

Neo-adjuvant chemotherapy in early stages of non-small cell lung cancerCRINO, Lucio.Lung cancer. 2002, Vol 38, pp S31-S32, issn 0169-5002, SUP3Article

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: A multicenter, randomized, phase II trialSCAGLIOTTI, Giorgio V; KORTSIK, Cornelius; NOVELLO, Silvia et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 690-696, issn 1078-0432, 7 p., 1Article

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational SUN (Survey on the lUng cancer maNagement) studyGRIDELLI, Cesare; ARDIZZONI, Andrea; ADAMO, Vincenzo et al.Lung cancer. 2011, Vol 74, Num 3, pp 462-468, issn 0169-5002, 7 p.Article

Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancerDZIADZIUSZKO, Rafal; WITTA, Samir E; VARELLA-GARCIA, Marileila et al.Clinical cancer research. 2006, Vol 12, Num 10, pp 3078-3084, issn 1078-0432, 7 p.Article

Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancerMARANZANO, Ernesto; CRINO, Lucio; LATINI, Paolo et al.Lung cancer. 2002, Vol 37, Num 1, pp 79-85, issn 0169-5002Article

Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancerNOVELLO, Silvia; GALLI, Luca; TONATO, Maurizio et al.Lung cancer. 2001, Vol 34, Num 2, pp 261-269, issn 0169-5002Article

Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated AnalysisMASI, Gianluca; VASILE, Enrico; FABBRI, Maria Agnese et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 1, pp 21-30, issn 0027-8874, 10 p.Article

EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients : how do we interpret the clinical and biomarker data?CALIFANO, Raffaele; BLACKHALL, Fiona H; FINOCCHIARO, Giovanna et al.Targeted oncology. 2008, Vol 3, Num 3, pp 173-186, issn 1776-2596, 14 p.Article

Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non-small-cell lung cancerJÄNNE, Pasi A; VON PAWEL, Joachim; DASSE, Kathy et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3936-3944, issn 0732-183X, 9 p.Article

Clinical experience with gefitinib : An updateCAPPUZZO, Federico; FINOCCHIARO, Giovanna; METRO, Giulio et al.Critical reviews in oncology/hematology. 2006, Vol 58, Num 1, pp 31-45, issn 1040-8428, 15 p.Article

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC)CAPPUZZO, Federico; ARDIZZONI, Andrea; SOTO-PARRA, Hector et al.Lung cancer. 2003, Vol 41, Num 2, pp 227-231, issn 0169-5002, 5 p.Article

Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancerCAPPUZZO, Federico; DE MARINIS, Filippo; ANDRUCCETTIA, Michele et al.Lung cancer. 2003, Vol 42, Num 3, pp 355-361, issn 0169-5002, 7 p.Article

Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancerSCAGLIOTTI, Giorgio V; FOSSATI, Roldano; TORRI, Valter et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 19, pp 1453-1461, issn 0027-8874, 9 p.Article

Targeted therapy in combination with gemcitabine in non-small cell lung cancerROSELL, Rafael; CRINO, Lucio; SANCHEZ, Jose Javier et al.Seminars in oncology. 2003, Vol 30, Num 4, pp 19-25, issn 0093-7754, 7 p., SUP10Article

Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcome in Resected Non-Small Cell Lung Cancer PatientsRAGUSA, Mark; VANNUCCI, Jacopo; PUMA, Francesco et al.American journal of clinical oncology. 2014, Vol 37, Num 4, pp 343-349, issn 0277-3732, 7 p.Article

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non―Small―Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 TrialARDIZZONI, Andrea; TISEO, Marcello; BONI, Corrado et al.Journal of clinical oncology. 2012, Vol 30, Num 36, pp 4501-4507, issn 0732-183X, 7 p.Article

Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational OncologyBIANCONI, Fortunato; BALDELLI, Elisa; LUDOVINI, Vienna et al.Biotechnology advances. 2012, Vol 30, Num 1, pp 142-153, issn 0734-9750, 12 p.Article

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from ItalyTISEO, Marcello; GRIDELLI, Cesare; BELVEDERE, Ornella et al.Lung cancer. 2009, Vol 64, Num 2, pp 199-206, issn 0169-5002, 8 p.Article

Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosisFRANCESCHI, Enrico; CAVALLO, Giovanna; SCOPECE, Luciano et al.Journal of neuro-oncology. 2005, Vol 73, Num 3, pp 261-264, issn 0167-594X, 4 p.Article